tradingkey.logo
tradingkey.logo
Buscar

Codexis Inc

CDXS
Añadir a la lista de seguimiento
2.460USD
-0.110-4.28%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
223.61MCap. mercado
PérdidaP/E TTM

Más Datos de Codexis Inc Compañía

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Información de Codexis Inc

Símbolo de cotizaciónCDXS
Nombre de la empresaCodexis Inc
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoMoore (Alison)
Número de empleados188
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección200 Penobscot Dr
CiudadREDWOOD CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94063
Teléfono16504218100
Sitio Webhttps://www.codexis.com/
Símbolo de cotizaciónCDXS
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoMoore (Alison)

Ejecutivos de Codexis Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
87.42K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
America
43.54M
61.85%
China
9.30M
13.21%
India
5.70M
8.10%
EMEA
4.39M
6.24%
Switzerland
4.20M
5.97%
Otro
3.26M
4.63%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: jue., 14 de may
Actualizado: jue., 14 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
abrdn Inc.
9.55%
Opaleye Management Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
6.72%
Millennium Management LLC
5.21%
Lytton (Laurence W)
4.99%
Otro
66.07%
Accionistas
Accionistas
Proporción
abrdn Inc.
9.55%
Opaleye Management Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
6.72%
Millennium Management LLC
5.21%
Lytton (Laurence W)
4.99%
Otro
66.07%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
26.66%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
20.76%
Individual Investor
7.41%
Research Firm
1.58%
Pension Fund
0.18%
Bank and Trust
0.16%
Venture Capital
0.08%
Otro
17.65%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
273
66.34M
73.00%
-13.88M
2025Q4
259
63.79M
84.44%
-3.19M
2025Q3
270
67.24M
85.39%
-6.33M
2025Q2
272
73.50M
96.12%
+3.66M
2025Q1
304
67.35M
93.04%
-9.72M
2024Q4
323
66.35M
93.32%
+1.38M
2024Q3
331
65.10M
96.64%
+10.35M
2024Q2
345
54.66M
101.93%
-1.25M
2024Q1
358
56.38M
110.38%
-21.50M
2023Q4
374
58.04M
110.76%
+374.07K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
abrdn Inc.
7.97M
8.77%
+3.87M
+94.68%
Dec 31, 2025
Opaleye Management Inc.
6.79M
7.47%
-4.94M
-42.13%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.11M
6.72%
+236.37K
+4.02%
Dec 31, 2025
Millennium Management LLC
3.14M
3.45%
-932.37K
-22.92%
Dec 31, 2025
Lytton (Laurence W)
4.53M
4.99%
+4.53M
--
Mar 06, 2026
Nantahala Capital Management, LLC
3.99M
4.39%
-40.45K
-1.00%
Dec 31, 2025
Telemark Asset Management, LLC
3.85M
4.23%
-153.59K
-3.84%
Dec 31, 2025
Columbia Threadneedle Investments (US)
3.79M
4.17%
+1.02M
+36.77%
Dec 31, 2025
UBS Financial Services, Inc.
809.52K
0.89%
+287.14K
+54.97%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Micro-Cap ETF
0.04%
Invesco Nasdaq Biotechnology ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.47%
iShares Micro-Cap ETF
Proporción0.04%
Invesco Nasdaq Biotechnology ETF
Proporción0.02%
Fidelity Enhanced Small Cap ETF
Proporción0.02%
iShares Biotechnology ETF
Proporción0.02%
ProShares Ultra Nasdaq Biotechnology
Proporción0.02%
Global X Russell 2000 ETF
Proporción0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI